Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

976
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
976
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

226
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
226
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

285
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
285
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

395
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Situ Oxygen Shuttling within a Bilayer Electrified Membrane Enables Aeration-Free Electro-Fenton Water Purification.

ACS nano·2026
Same author

Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework.

Frontiers in cardiovascular medicine·2026
Same author

Interfacial Polycondensation Kinetics Regulation Enables Microporous Polyesteramide Membranes for Ultraselective Water Purification.

Environmental science & technology·2026
Same author

Neural mechanisms of structural inference: An EEG investigation of linguistic phrase structure categorization.

Brain and language·2026
Same author

Bifidobacterium breve BBr60 Improves Metabolic Abnormalities by Regulating Gut Microbiota Balance in a High-Fat Diet-Induced Obese Mouse Model.

Diabetes, obesity & metabolism·2026
Same author

Cell-based drug delivery for combating bacteria: focus on refractory infections.

Journal of nanobiotechnology·2026
Same journal

iNOS/NO-Induced autophagy primes PANoptosis as the central driver of streptococcal toxic shock-like syndrome in zoonotic <i>Streptococcus suis</i> infection.

Emerging microbes & infections·2026
Same journal

Beyond H5N1: Influenza A virus infection in bovine udder organoids.

Emerging microbes & infections·2026
Same journal

Development and validation of the AI-predictive ParaScout <i>In-Vitro</i> Diagnostic (IVD) system for the microscopic detection of gastro-intestinal helminths in stool.

Emerging microbes & infections·2026
Same journal

Genomic landscape and phylogenetic insights of <i>Burkholderia pseudomallei</i> over two decades in southern China and its global surveillance.

Emerging microbes & infections·2026
Same journal

Quantifying the community transmission of <i>Mycobacterium tuberculosis</i> in a rapidly growing Chinese city: a nine-year population-based genomic and spatial analysis.

Emerging microbes & infections·2026
Same journal

Spatiotemporal dynamics of the unprecedented chikungunya outbreak in Guangdong, China.

Emerging microbes & infections·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K

Challenges facing long-acting PrEP implementation in large populations.

Caijun Sun1,2,3, Yu Liao1

  • 1Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, People's Republic of China.

Emerging Microbes & Infections
|April 21, 2026
PubMed
Summary
This summary is machine-generated.

Long-acting injectable lenacapavir offers a significant advancement in HIV prevention by overcoming adherence challenges associated with daily oral pre-exposure prophylaxis (PrEP). This new formulation is particularly beneficial for high-incidence regions and specific populations.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.1K

Related Experiment Videos

Last Updated: Apr 22, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.1K

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Daily oral pre-exposure prophylaxis (PrEP) faces adherence limitations in real-world HIV prevention.
  • Long-acting antiretroviral therapies represent a novel approach to enhance HIV prevention strategies.

Purpose of the Study:

  • To highlight the potential of long-acting antiviral prophylaxis, specifically lenacapavir, in HIV prevention.
  • To address the adherence challenges limiting the effectiveness of daily oral PrEP.

Main Methods:

  • Review of advancements in antiviral prophylaxis.
  • Focus on the characteristics and application of injectable lenacapavir.

Main Results:

  • Lenacapavir, a twice-yearly injectable capsid inhibitor, demonstrates a significant advance in HIV prevention.
  • Long-acting formulations address adherence issues, improving upon daily oral PrEP.

Conclusions:

  • Long-acting lenacapavir provides a potent HIV prevention tool.
  • This approach is especially suitable for populations and regions with high HIV incidence and transmission rates.